Follow The Filings

VCEL Vericel Corporation

Health Care, filed as VERICEL CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.0%
  • $1.2M

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Mairs & Power). Not free-float ownership.

  1. Mairs & Power 0.01%

Who owns VCEL

Sorted by value, long equity only, as of 2026 Q2.

History
Mairs & Power 0.01% Hold 25,865 $1.2M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by VCEL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VCEL insider trades
  • None no insider bought on the open market
  • $517K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Paul K Wotton Director
    Sale
    $327K 10,000 shares at $32.74 35% of stake
    Traded May 11 Filed May 13
    ↗
  2. Paul K Wotton Director
    Sale
    $190K 5,000 shares at $37.90 16% of stake
    Traded Dec 2–3 Filed Dec 4, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 56 option exercises, 30 sales to cover taxes, and 21 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.03,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A DEFINITIVE PROXY STATEMENT Filing Doc
DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $197.52M $237.22M $276.26M
Gross profit $135.58M $172.11M $205.6M
Gross margin * 68.6% 72.6% 74.4%
Net income -$3.18M $10.36M $16.52M
Net margin * -1.6% 4.4% 6.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $205.63M $212.78M $247.44M
Total non-current assets * $148.03M $219.94M $240.53M
Total assets $353.66M $432.72M $487.97M
Total current liabilities $45.75M $50.29M $49.15M
Total non-current liabilities * $81.96M $90.47M $84.18M
Total equity $225.95M $291.97M $354.64M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $35.31M $58.16M $51.91M
Cash from investing -$3.13M -$79.03M -$43.94M
Cash from financing $3.62M $19.05M $7.07M
Net change in cash $35.8M -$1.82M $15.04M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.